Clinical Trial Update: A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

View source ↗

Summary

Update from a completed clinical trial examining how frequently the I50L resistance mutation appears in HIV patients who fail regimens containing atazanavir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Status: COMPLETED